You have 9 free searches left this month | for more free features.

City

Fuzhou (1)

Guangzhou (1)

Condition

Nasopharyngeal Carcinoma (2)

Chemotherapy (1)

Immunotherapy (1)

Metastasis (1)

Survival (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Fujian Cancer Hospital (1)

Sun Yat-sen University (1)

Collaborator

Jiangxi Provincial Cancer Hospital (1)

Shanghai Junshi Bioscience Co., Ltd. (1)

Zhejiang Cancer Hospital (1)

Intervention

triprilimab(js001) (2)

5-fluorouracil (1)

cisplatin (1)

gemcitabine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

triprilimab(js001)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Nasopharyngeal Carcinoma, Metastasis, Chemo Trial in Guangzhou (Triprilimab(JS001), Cisplatin, 5-Fluorouracil)

Not yet recruiting

Nasopharyngeal Carcinoma
+4 more

Triprilimab(JS001)
+3 more

Guangzhou, Guangdong, China

Department of Radiation Oncology, Sun Yat-Sen University Cancer

May 16, 2021

Nasopharyngeal Carcinoma Trial in Fuzhou (Triprilimab(JS001))

Not yet recruiting

Nasopharyngeal Carcinoma

Triprilimab(JS001)

Fuzhou, Fujian, China

Department of radiation oncology, Fujian cancer hospital

Jun 5, 2020